carbapenems has been researched along with Acute Lymphoid Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asch, J; Bo Petersen, F; Burke, JP; Dascomb, KK; Ford, CD; Haydoura, S; Lopansri, BK; Snow, G | 1 |
| Horowitz, A; Muchtar, E; Paul, M; Raanani, P; Shpilberg, O | 1 |
| Aytac, S; Cengiz, AB; Cetin, M; Ceyhan, M; Secmeer, G; Tuncer, M; Yetgin, S; Yildirim, I | 1 |
1 trial(s) available for carbapenems and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2008 |
2 other study(ies) available for carbapenems and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Bacteremia; Carbapenems; Carrier State; Diarrhea; Febrile Neutropenia; Female; Gram-Positive Bacterial Infections; Humans; Length of Stay; Leukemia, Myeloid, Acute; Male; Middle Aged; Molecular Typing; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Risk Factors; Vancomycin-Resistant Enterococci; Young Adult | 2015 |
Persistent carbapenem-resistant Klebsiella pneumoniae bacteremia in a patient with acute lymphoblastic leukemia.
Topics: Bacteremia; beta-Lactam Resistance; Carbapenems; Catheter-Related Infections; Catheterization, Central Venous; Drug Resistance, Multiple; Fatal Outcome; Female; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2012 |